Troy, N.Y. — A new biochip technology could eliminate animal testing in the chemicals and cosmetics industries, and drastically curtail its use in the development of new pharmaceuticals, according to new findings from a team of researchers at Rensselaer Polytechnic Institute, the University of California at Berkeley, and Solidus Biosciences Inc. The team’s most recent discovery will be featured in the online Early Edition of the Proceedings of the National Academy of Sciences (PNAS) on Dec. 17.
